Adjunctive Nephrectomy at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer

Journal of Urology

Volumn 176, Issue 5, 2006, Pages 1996-1999

  Stephenson, Andrew J ^a   Tal, Raanan ^a   Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

kidney failure; nephrectomy; retroperitoneal neoplasms; salvage therapy; testicular neoplasms

Indexed keywords

CISPLATIN; CREATININE;

AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE FREE SURVIVAL; FOLLOW UP; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; NONSEMINOMATOUS GERM CELL TESTICULAR CANCER; PRIORITY JOURNAL; SALVAGE THERAPY; SURVIVAL TIME; TESTIS CANCER;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; NEPHRECTOMY; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS;

EID: 33750285613     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.07.050     Document Type: Article

References (16)

1. International Germ Cell Consensus Classification, and International Germ Cell Cancer Collaborative Group. a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15 (1997) 594
2. Beck S.D., Foster R.S., Bihrle R., Ulbright T., Koch M.O., Wahle G.R., et al. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. J Urol 168 (2002) 1402
3. Oldenburg J., Alfsen G.C., Lien H.H., Aass N., Waehre H., and Fossa S.D. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21 (2003) 3310
4. Patel M.I., Beck S., Bosl G.J., Motzer R., Bajorin D., and Sheinfeld J. Histology of good risk non-seminomatous germ cell tumor (NSGCT) patients following retroperitoneal lymph node dissection (PC-RPLND) after four cycles of etoposide and cisplatin (EPX4). abstract 681. J Urol 169 suppl (2003) 176
5. Toner G.C., Panicek D.M., Heelan R.T., Geller N.L., Lin S.Y., Bajorin D., et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8 (1990) 1683
6. Carver B.S., Motzer R.J., Bajorin D.F., Stasi J., Bosl G.J., and Sheinfeld J. Post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumors: the impact of time. abstract. Proc Am Soc Clin Oncol 24 (2005) 4581
7. Donohue J.P., Leviovitch I., Foster R.S., Baniel J., and Tognoni P. Integration of surgery and systemic therapy: results and principles of integration. Semin Urol Oncol 16 (1998) 65
8. Mosharafa A.A., Foster R.S., Koch M.O., Bihrle R., and Donohue J.P. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 171 (2004) 1839
9. Nash P.A., Leibovitch I., Foster R.S., Bihrle R., Rowland R.G., and Donohue J.P. En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes. J Urol 159 (1998) 707
10. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31
11. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457
12. McKiernan J.M., Motzer R.J., Bajorin D.F., Bacik J., Bosl G.J., and Sheinfeld J. Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome. Urology 62 (2003) 732
13. Sharp, D. S., Carver, B. S., Eggener, S. E., Motzer, R. J., Bosl, G. J. and Sheinfeld, J.: Clinical outcome of patients managed for late relapse of germ cell tumor. Unpublished data
14. Sheinfeld J. Risks of the uncontrolled retroperitoneum. Ann Surg Oncol 10 (2003) 100
15. George D.W., Foster R.S., Hromas R.A., Robertson K.A., Vance G.H., Ulbright T.M., et al. Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol 21 (2003) 113
16. Meinardi M.T., Gietema J.A., van der Graaf W.T., van Veldhuisen D.J., Runne M.A., and Sluiter W.J. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18 (2000) 1725